Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.20115118 |
2 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.81787749 |
3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.46484134 |
4 | locomotory exploration behavior (GO:0035641) | 4.45614051 |
5 | histone H3-K36 demethylation (GO:0070544) | 4.28076471 |
6 | synaptic vesicle maturation (GO:0016188) | 4.26674155 |
7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.20420665 |
8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19643552 |
9 | vocalization behavior (GO:0071625) | 4.12552179 |
10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.03929047 |
11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.00485509 |
12 | synaptic vesicle exocytosis (GO:0016079) | 3.95665750 |
13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.93388677 |
14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.92077413 |
15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.90126777 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.85793009 |
17 | protein localization to synapse (GO:0035418) | 3.80607572 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.78596337 |
19 | interkinetic nuclear migration (GO:0022027) | 3.73607309 |
20 | glutamate receptor signaling pathway (GO:0007215) | 3.68116301 |
21 | * cerebellar Purkinje cell differentiation (GO:0021702) | 3.67898124 |
22 | neuron cell-cell adhesion (GO:0007158) | 3.65204804 |
23 | glutamate secretion (GO:0014047) | 3.58581941 |
24 | cellular response to ethanol (GO:0071361) | 3.58014952 |
25 | positive T cell selection (GO:0043368) | 3.57724935 |
26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.56236512 |
27 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.55933970 |
28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.51235808 |
29 | regulation of ARF protein signal transduction (GO:0032012) | 3.50709487 |
30 | synaptic vesicle endocytosis (GO:0048488) | 3.49729864 |
31 | layer formation in cerebral cortex (GO:0021819) | 3.48262031 |
32 | synaptic transmission, glutamatergic (GO:0035249) | 3.42140669 |
33 | regulation of synaptic vesicle transport (GO:1902803) | 3.39668014 |
34 | neurotransmitter secretion (GO:0007269) | 3.39290139 |
35 | B cell receptor signaling pathway (GO:0050853) | 3.38512905 |
36 | sodium ion export (GO:0071436) | 3.35091124 |
37 | exploration behavior (GO:0035640) | 3.34919558 |
38 | cellular potassium ion homeostasis (GO:0030007) | 3.31098143 |
39 | histone H3-K9 demethylation (GO:0033169) | 3.29895686 |
40 | membrane depolarization during action potential (GO:0086010) | 3.28358502 |
41 | nucleus localization (GO:0051647) | 3.27345144 |
42 | positive regulation of granulocyte differentiation (GO:0030854) | 3.26724976 |
43 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.24959043 |
44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.24403488 |
45 | proline transport (GO:0015824) | 3.24254026 |
46 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.23258102 |
47 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.21650437 |
48 | vesicle transport along microtubule (GO:0047496) | 3.21377425 |
49 | neuron-neuron synaptic transmission (GO:0007270) | 3.20335988 |
50 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.15001529 |
51 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14463735 |
52 | long-term memory (GO:0007616) | 3.14413344 |
53 | positive regulation of synapse maturation (GO:0090129) | 3.13178461 |
54 | establishment of nucleus localization (GO:0040023) | 3.12520007 |
55 | regulation of synapse structural plasticity (GO:0051823) | 3.12177487 |
56 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.11580951 |
57 | regulation of postsynaptic membrane potential (GO:0060078) | 3.11330311 |
58 | neuronal action potential propagation (GO:0019227) | 3.10833001 |
59 | innervation (GO:0060384) | 3.08614725 |
60 | histone lysine demethylation (GO:0070076) | 3.08536088 |
61 | negative T cell selection (GO:0043383) | 3.08416859 |
62 | negative thymic T cell selection (GO:0045060) | 3.07734523 |
63 | peptidyl-lysine trimethylation (GO:0018023) | 3.05624031 |
64 | dendrite morphogenesis (GO:0048813) | 3.04214124 |
65 | establishment of protein localization to Golgi (GO:0072600) | 3.02687478 |
66 | axonal fasciculation (GO:0007413) | 3.02218900 |
67 | histone H3-K4 trimethylation (GO:0080182) | 3.01619021 |
68 | protein targeting to Golgi (GO:0000042) | 3.01432434 |
69 | positive regulation of Rap GTPase activity (GO:0032854) | 3.01183733 |
70 | dendritic spine morphogenesis (GO:0060997) | 3.00530226 |
71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.99772236 |
72 | neuron recognition (GO:0008038) | 2.99199325 |
73 | histone demethylation (GO:0016577) | 2.97667977 |
74 | activation of protein kinase A activity (GO:0034199) | 2.96932095 |
75 | positive thymic T cell selection (GO:0045059) | 2.96706122 |
76 | activated T cell proliferation (GO:0050798) | 2.96430064 |
77 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.95441655 |
78 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.94477968 |
79 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.93136839 |
80 | lipid translocation (GO:0034204) | 2.93110168 |
81 | phospholipid translocation (GO:0045332) | 2.93110168 |
82 | gamma-aminobutyric acid transport (GO:0015812) | 2.91760893 |
83 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.90715173 |
84 | Golgi to endosome transport (GO:0006895) | 2.89378988 |
85 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.88847374 |
86 | prepulse inhibition (GO:0060134) | 2.88597052 |
87 | regulation of Rap GTPase activity (GO:0032317) | 2.87991126 |
88 | cellular response to epinephrine stimulus (GO:0071872) | 2.86684761 |
89 | protein K48-linked deubiquitination (GO:0071108) | 2.86077109 |
90 | long-term synaptic potentiation (GO:0060291) | 2.84063742 |
91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.83994539 |
92 | regulation of neurotransmitter secretion (GO:0046928) | 2.83419069 |
93 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.81790369 |
94 | membrane depolarization (GO:0051899) | 2.81645285 |
95 | presynaptic membrane assembly (GO:0097105) | 2.77775223 |
96 | peptidyl-threonine phosphorylation (GO:0018107) | 2.77453762 |
97 | cell communication by electrical coupling (GO:0010644) | 2.75818373 |
98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.75774191 |
99 | macroautophagy (GO:0016236) | 2.75047264 |
100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74679346 |
101 | negative regulation of cell killing (GO:0031342) | 2.74679346 |
102 | histone H3-K9 modification (GO:0061647) | 2.74301038 |
103 | skeletal muscle adaptation (GO:0043501) | 2.73936777 |
104 | striatum development (GO:0021756) | 2.72488500 |
105 | protein K11-linked deubiquitination (GO:0035871) | 2.71530705 |
106 | myofibril assembly (GO:0030239) | 2.70446865 |
107 | positive regulation of membrane potential (GO:0045838) | 2.69552295 |
108 | transmission of nerve impulse (GO:0019226) | 2.69140742 |
109 | neurotransmitter transport (GO:0006836) | 2.68875037 |
110 | cellular extravasation (GO:0045123) | 2.68621563 |
111 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.68510296 |
112 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.67635880 |
113 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.67635880 |
114 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.67635880 |
115 | histone H3-K4 methylation (GO:0051568) | 2.67299695 |
116 | organelle transport along microtubule (GO:0072384) | 2.66468554 |
117 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.64113449 |
118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63782450 |
119 | regulation of synaptic plasticity (GO:0048167) | 2.63616135 |
120 | T cell selection (GO:0045058) | 2.62901947 |
121 | response to histamine (GO:0034776) | 2.61010912 |
122 | cell migration in hindbrain (GO:0021535) | 2.60726494 |
123 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60373649 |
124 | regulation of synapse maturation (GO:0090128) | 2.59732157 |
125 | presynaptic membrane organization (GO:0097090) | 2.59198602 |
126 | negative regulation of inclusion body assembly (GO:0090084) | 2.58458663 |
127 | synapse assembly (GO:0007416) | 2.58097493 |
128 | protein dealkylation (GO:0008214) | 2.57376483 |
129 | protein demethylation (GO:0006482) | 2.57376483 |
130 | membrane hyperpolarization (GO:0060081) | 2.56705366 |
131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.56577969 |
132 | definitive hemopoiesis (GO:0060216) | 2.56490359 |
133 | nerve growth factor signaling pathway (GO:0038180) | 2.56301639 |
134 | peptidyl-lysine methylation (GO:0018022) | 2.55890722 |
135 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.55733643 |
136 | histone lysine methylation (GO:0034968) | 2.55722987 |
137 | clathrin coat assembly (GO:0048268) | 2.55226279 |
138 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.55091161 |
139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54607256 |
140 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.54284819 |
141 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.54020039 |
142 | response to epinephrine (GO:0071871) | 2.54018791 |
143 | regulation of protein polyubiquitination (GO:1902914) | 2.52810051 |
144 | postsynaptic membrane organization (GO:0001941) | 2.52536589 |
145 | stress granule assembly (GO:0034063) | 2.52407140 |
146 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.51410030 |
147 | peptidyl-threonine modification (GO:0018210) | 2.50583075 |
148 | detection of calcium ion (GO:0005513) | 2.50318401 |
149 | regulation of neurotransmitter transport (GO:0051588) | 2.50154245 |
150 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.50028060 |
151 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.49574941 |
152 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.49326769 |
153 | regulation of dendritic spine development (GO:0060998) | 2.48361027 |
154 | regulation of beta-amyloid formation (GO:1902003) | 2.47718117 |
155 | striated muscle atrophy (GO:0014891) | 2.47093733 |
156 | negative regulation of neurotransmitter transport (GO:0051589) | 2.44454913 |
157 | germinal center formation (GO:0002467) | 2.43610934 |
158 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.43410515 |
159 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.41225264 |
160 | protein K63-linked deubiquitination (GO:0070536) | 2.40127431 |
161 | response to interleukin-15 (GO:0070672) | 2.37919966 |
162 | histone H3-K9 methylation (GO:0051567) | 2.36412889 |
163 | dosage compensation (GO:0007549) | 2.35773775 |
164 | regulation of relaxation of muscle (GO:1901077) | 2.35490470 |
165 | regulation of granulocyte differentiation (GO:0030852) | 2.35121526 |
166 | cardiac muscle hypertrophy (GO:0003300) | 2.33972102 |
167 | peptidyl-serine phosphorylation (GO:0018105) | 2.33237149 |
168 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32365285 |
169 | thymic T cell selection (GO:0045061) | 2.32246792 |
170 | regulation of histone H3-K27 methylation (GO:0061085) | 2.30852208 |
171 | microglial cell activation (GO:0001774) | 2.30560223 |
172 | growth hormone receptor signaling pathway (GO:0060396) | 2.28811572 |
173 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.27811028 |
174 | phosphatidylinositol phosphorylation (GO:0046854) | 2.26737371 |
175 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.25690884 |
176 | regulation of pigment cell differentiation (GO:0050932) | 2.25209255 |
177 | negative regulation of T cell mediated immunity (GO:0002710) | 2.23661689 |
178 | hepatocyte apoptotic process (GO:0097284) | 2.22320120 |
179 | cellular response to catecholamine stimulus (GO:0071870) | 2.21762655 |
180 | cellular response to monoamine stimulus (GO:0071868) | 2.21762655 |
181 | histone mRNA catabolic process (GO:0071044) | 2.21515392 |
182 | striated muscle hypertrophy (GO:0014897) | 2.20314270 |
183 | striated muscle adaptation (GO:0014888) | 2.18510887 |
184 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.17537964 |
185 | positive regulation of B cell differentiation (GO:0045579) | 2.17285134 |
186 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.16252810 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.67246204 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.68430709 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.10164698 |
4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.50823688 |
5 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.44927852 |
6 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.39841686 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37433804 |
8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30584643 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19270131 |
10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.18129136 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14219261 |
12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.10702965 |
13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09808136 |
14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.04793598 |
15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97550096 |
16 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93066090 |
17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88439050 |
18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.86032435 |
19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80516716 |
20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77100741 |
21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77100741 |
22 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75512836 |
23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75475934 |
24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74778258 |
25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74592061 |
26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73618127 |
27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73056113 |
28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.71411819 |
29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70686348 |
30 | STAT3_23295773_ChIP-Seq_U87_Human | 1.67142570 |
31 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67077447 |
32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.65680313 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65674435 |
34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63442125 |
35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62335640 |
36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61757489 |
37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61317848 |
38 | TP53_16413492_ChIP-PET_HCT116_Human | 1.61001386 |
39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60254216 |
40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59867008 |
41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57214947 |
42 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56315778 |
43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55239415 |
44 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.54909715 |
45 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54577697 |
46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54556502 |
47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53816193 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52702209 |
49 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.51771291 |
50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51673086 |
51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.48950267 |
52 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48050037 |
53 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46266695 |
54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45140943 |
55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.42613796 |
56 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41552423 |
57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41479797 |
58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.40680326 |
59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40530143 |
60 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40454328 |
61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39566047 |
62 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.39379797 |
63 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.38267118 |
64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37871801 |
65 | AR_19668381_ChIP-Seq_PC3_Human | 1.37535605 |
66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36694981 |
67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36605563 |
68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35735431 |
69 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35639916 |
70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35218154 |
71 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33661194 |
72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33107724 |
73 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32816438 |
74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32004722 |
75 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31980599 |
76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.30588423 |
77 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.28751838 |
78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28403756 |
79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27875606 |
80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26372021 |
81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25965878 |
82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25551422 |
83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.25385549 |
84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24998003 |
85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23837445 |
86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23837445 |
87 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.22671334 |
88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22423271 |
89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21592431 |
90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21302997 |
91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21256694 |
92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19659518 |
93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19576729 |
94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19330258 |
95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18756350 |
96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16476700 |
97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.15910495 |
98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15906006 |
99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14385968 |
100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13406196 |
101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.12271546 |
102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11915929 |
103 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09722776 |
104 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09559417 |
105 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09403952 |
106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07198504 |
107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07059438 |
108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06780564 |
109 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06356703 |
110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.05980628 |
111 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05723807 |
112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05574843 |
113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05374604 |
114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05248776 |
115 | MYB_26560356_Chip-Seq_TH2_Human | 1.04748065 |
116 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03690893 |
117 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02659974 |
118 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01283288 |
119 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00621076 |
120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00258204 |
121 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99857108 |
122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99282395 |
123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98510377 |
124 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98425441 |
125 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98035179 |
126 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97243789 |
127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97057802 |
128 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96942722 |
129 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96203801 |
130 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96053690 |
131 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95832538 |
132 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94689763 |
133 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94610982 |
134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94579548 |
135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93927410 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93212225 |
137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93212225 |
138 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92775366 |
139 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92668881 |
140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92555350 |
141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92204726 |
142 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91390893 |
143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91260631 |
144 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90870235 |
145 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90693523 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.42404604 |
2 | MP0000569_abnormal_digit_pigmentation | 5.14649550 |
3 | MP0003880_abnormal_central_pattern | 3.61223103 |
4 | MP0003635_abnormal_synaptic_transmissio | 3.51691803 |
5 | MP0003787_abnormal_imprinting | 3.45593115 |
6 | MP0008057_abnormal_DNA_replication | 3.36159993 |
7 | MP0004270_analgesia | 3.10122772 |
8 | MP0009046_muscle_twitch | 2.96687448 |
9 | MP0009745_abnormal_behavioral_response | 2.87094643 |
10 | MP0002063_abnormal_learning/memory/cond | 2.82528771 |
11 | MP0003763_abnormal_thymus_physiology | 2.79218409 |
12 | MP0004130_abnormal_muscle_cell | 2.72197057 |
13 | MP0005423_abnormal_somatic_nervous | 2.65123899 |
14 | MP0002064_seizures | 2.56341437 |
15 | MP0001968_abnormal_touch/_nociception | 2.49362125 |
16 | MP0002572_abnormal_emotion/affect_behav | 2.39114628 |
17 | MP0002734_abnormal_mechanical_nocicepti | 2.28338507 |
18 | MP0001486_abnormal_startle_reflex | 2.25837857 |
19 | MP0003646_muscle_fatigue | 2.25460206 |
20 | MP0004036_abnormal_muscle_relaxation | 2.18755427 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 2.15458326 |
22 | MP0009780_abnormal_chondrocyte_physiolo | 2.15344319 |
23 | MP0002735_abnormal_chemical_nociception | 2.11625855 |
24 | MP0002272_abnormal_nervous_system | 2.06523460 |
25 | MP0004084_abnormal_cardiac_muscle | 2.03457846 |
26 | MP0008877_abnormal_DNA_methylation | 1.93385257 |
27 | * MP0002067_abnormal_sensory_capabilities | 1.92172260 |
28 | MP0001501_abnormal_sleep_pattern | 1.85648692 |
29 | MP0008569_lethality_at_weaning | 1.85599914 |
30 | MP0002332_abnormal_exercise_endurance | 1.84803116 |
31 | MP0000778_abnormal_nervous_system | 1.84001418 |
32 | MP0005451_abnormal_body_composition | 1.82345234 |
33 | MP0003303_peritoneal_inflammation | 1.81619213 |
34 | MP0002166_altered_tumor_susceptibility | 1.81558165 |
35 | MP0003828_pulmonary_edema | 1.80857938 |
36 | MP0001440_abnormal_grooming_behavior | 1.78545949 |
37 | MP0002736_abnormal_nociception_after | 1.75740704 |
38 | MP0005645_abnormal_hypothalamus_physiol | 1.74352962 |
39 | MP0002184_abnormal_innervation | 1.72438269 |
40 | MP0004381_abnormal_hair_follicle | 1.72291771 |
41 | MP0004924_abnormal_behavior | 1.72015122 |
42 | MP0005386_behavior/neurological_phenoty | 1.72015122 |
43 | MP0004811_abnormal_neuron_physiology | 1.71412588 |
44 | MP0003690_abnormal_glial_cell | 1.68403553 |
45 | MP0002557_abnormal_social/conspecific_i | 1.64869190 |
46 | MP0001984_abnormal_olfaction | 1.64560543 |
47 | MP0005646_abnormal_pituitary_gland | 1.64362879 |
48 | MP0002822_catalepsy | 1.61253617 |
49 | MP0002909_abnormal_adrenal_gland | 1.60210812 |
50 | MP0003724_increased_susceptibility_to | 1.57334559 |
51 | MP0002733_abnormal_thermal_nociception | 1.57238765 |
52 | MP0000749_muscle_degeneration | 1.55162348 |
53 | MP0003121_genomic_imprinting | 1.50807471 |
54 | MP0001970_abnormal_pain_threshold | 1.47281714 |
55 | MP0008260_abnormal_autophagy | 1.46861067 |
56 | MP0003122_maternal_imprinting | 1.43931009 |
57 | MP0000955_abnormal_spinal_cord | 1.42425154 |
58 | MP0001188_hyperpigmentation | 1.41393256 |
59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.39422702 |
60 | MP0005551_abnormal_eye_electrophysiolog | 1.38441538 |
61 | MP0001835_abnormal_antigen_presentation | 1.34686167 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.34617264 |
63 | MP0003045_fibrosis | 1.32240088 |
64 | MP0001502_abnormal_circadian_rhythm | 1.32154824 |
65 | MP0006276_abnormal_autonomic_nervous | 1.31541032 |
66 | MP0001800_abnormal_humoral_immune | 1.30413051 |
67 | MP0003633_abnormal_nervous_system | 1.28918080 |
68 | * MP0002882_abnormal_neuron_morphology | 1.27654921 |
69 | MP0003183_abnormal_peptide_metabolism | 1.27576789 |
70 | MP0005310_abnormal_salivary_gland | 1.25440720 |
71 | MP0003091_abnormal_cell_migration | 1.23049663 |
72 | MP0002396_abnormal_hematopoietic_system | 1.22971352 |
73 | MP0000015_abnormal_ear_pigmentation | 1.22006225 |
74 | MP0004087_abnormal_muscle_fiber | 1.21570609 |
75 | MP0002106_abnormal_muscle_physiology | 1.17107089 |
76 | MP0008961_abnormal_basal_metabolism | 1.16419178 |
77 | MP0004858_abnormal_nervous_system | 1.14993294 |
78 | MP0000703_abnormal_thymus_morphology | 1.14027324 |
79 | MP0003879_abnormal_hair_cell | 1.13231153 |
80 | MP0002398_abnormal_bone_marrow | 1.10745583 |
81 | * MP0002066_abnormal_motor_capabilities/c | 1.10716848 |
82 | MP0000465_gastrointestinal_hemorrhage | 1.10267063 |
83 | MP0002009_preneoplasia | 1.10094419 |
84 | * MP0002152_abnormal_brain_morphology | 1.09079094 |
85 | MP0003631_nervous_system_phenotype | 1.08513433 |
86 | MP0000759_abnormal_skeletal_muscle | 1.07607546 |
87 | MP0002269_muscular_atrophy | 1.00119521 |
88 | MP0003866_abnormal_defecation | 0.99690252 |
89 | MP0005397_hematopoietic_system_phenotyp | 0.99677875 |
90 | MP0001545_abnormal_hematopoietic_system | 0.99677875 |
91 | MP0009115_abnormal_fat_cell | 0.96948771 |
92 | MP0005620_abnormal_muscle_contractility | 0.95559309 |
93 | MP0004145_abnormal_muscle_electrophysio | 0.94490802 |
94 | MP0005174_abnormal_tail_pigmentation | 0.94391513 |
95 | MP0005409_darkened_coat_color | 0.93820197 |
96 | MP0006072_abnormal_retinal_apoptosis | 0.93401549 |
97 | MP0002127_abnormal_cardiovascular_syste | 0.93374800 |
98 | MP0000631_abnormal_neuroendocrine_gland | 0.92935237 |
99 | MP0002971_abnormal_brown_adipose | 0.92706554 |
100 | MP0001851_eye_inflammation | 0.92395604 |
101 | MP0004215_abnormal_myocardial_fiber | 0.92247603 |
102 | MP0004742_abnormal_vestibular_system | 0.91840223 |
103 | * MP0002229_neurodegeneration | 0.91615240 |
104 | MP0001299_abnormal_eye_distance/ | 0.91378957 |
105 | MP0002420_abnormal_adaptive_immunity | 0.91348181 |
106 | MP0004510_myositis | 0.91189469 |
107 | MP0003172_abnormal_lysosome_physiology | 0.91135753 |
108 | MP0004085_abnormal_heartbeat | 0.91097075 |
109 | MP0010630_abnormal_cardiac_muscle | 0.90877540 |
110 | MP0004885_abnormal_endolymph | 0.90681632 |
111 | MP0001819_abnormal_immune_cell | 0.87910694 |
112 | MP0005369_muscle_phenotype | 0.86583862 |
113 | MP0000751_myopathy | 0.85523098 |
114 | MP0004883_abnormal_blood_vessel | 0.85330614 |
115 | MP0000689_abnormal_spleen_morphology | 0.84911558 |
116 | MP0005394_taste/olfaction_phenotype | 0.84628269 |
117 | MP0005499_abnormal_olfactory_system | 0.84628269 |
118 | MP0000013_abnormal_adipose_tissue | 0.84317255 |
119 | MP0004147_increased_porphyrin_level | 0.83133750 |
120 | MP0000716_abnormal_immune_system | 0.83006186 |
121 | MP0005253_abnormal_eye_physiology | 0.82935767 |
122 | MP0002722_abnormal_immune_system | 0.82481519 |
123 | MP0000685_abnormal_immune_system | 0.82437377 |
124 | MP0002006_tumorigenesis | 0.81869723 |
125 | MP0005464_abnormal_platelet_physiology | 0.79813596 |
126 | MP0001177_atelectasis | 0.79682208 |
127 | MP0002723_abnormal_immune_serum | 0.79581901 |
128 | MP0006138_congestive_heart_failure | 0.79191239 |
129 | MP0003632_abnormal_nervous_system | 0.78812141 |
130 | MP0005076_abnormal_cell_differentiation | 0.78596614 |
131 | MP0005266_abnormal_metabolism | 0.78436962 |
132 | MP0008995_early_reproductive_senescence | 0.76977871 |
133 | MP0000747_muscle_weakness | 0.75935395 |
134 | MP0003329_amyloid_beta_deposits | 0.75727686 |
135 | MP0002452_abnormal_antigen_presenting | 0.75243564 |
136 | MP0003868_abnormal_feces_composition | 0.73861987 |
137 | MP0003890_abnormal_embryonic-extraembry | 0.70932959 |
138 | MP0005167_abnormal_blood-brain_barrier | 0.70902698 |
139 | MP0002419_abnormal_innate_immunity | 0.70826677 |
140 | MP0002069_abnormal_eating/drinking_beha | 0.70256887 |
141 | MP0002168_other_aberrant_phenotype | 0.70012218 |
142 | MP0008872_abnormal_physiological_respon | 0.68273927 |
143 | MP0003861_abnormal_nervous_system | 0.67828005 |
144 | MP0004233_abnormal_muscle_weight | 0.67586554 |
145 | MP0010386_abnormal_urinary_bladder | 0.67484629 |
146 | MP0002638_abnormal_pupillary_reflex | 0.67284571 |
147 | MP0003300_gastrointestinal_ulcer | 0.64982448 |
148 | MP0002090_abnormal_vision | 0.64943938 |
149 | MP0005187_abnormal_penis_morphology | 0.64561994 |
150 | MP0004484_altered_response_of | 0.63798880 |
151 | MP0001943_abnormal_respiration | 0.62085357 |
152 | MP0005535_abnormal_body_temperature | 0.61924145 |
153 | MP0010770_preweaning_lethality | 0.61838689 |
154 | MP0002082_postnatal_lethality | 0.61838689 |
155 | MP0005171_absent_coat_pigmentation | 0.61163015 |
156 | MP0003698_abnormal_male_reproductive | 0.60232286 |
157 | MP0002752_abnormal_somatic_nervous | 0.60059767 |
158 | * MP0010769_abnormal_survival | 0.60022363 |
159 | MP0008874_decreased_physiological_sensi | 0.59557142 |
160 | MP0001963_abnormal_hearing_physiology | 0.58618006 |
161 | * MP0010768_mortality/aging | 0.57578805 |
162 | MP0003634_abnormal_glial_cell | 0.56014529 |
163 | MP0002095_abnormal_skin_pigmentation | 0.55986158 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Febrile seizures (HP:0002373) | 4.94983128 |
2 | Focal motor seizures (HP:0011153) | 4.88562042 |
3 | Focal seizures (HP:0007359) | 4.69145589 |
4 | Epileptic encephalopathy (HP:0200134) | 4.13917618 |
5 | Difficulty running (HP:0009046) | 3.80558738 |
6 | Progressive cerebellar ataxia (HP:0002073) | 3.76237321 |
7 | Atonic seizures (HP:0010819) | 3.44872351 |
8 | Macroorchidism (HP:0000053) | 3.26168925 |
9 | Gaze-evoked nystagmus (HP:0000640) | 3.23554898 |
10 | Visual hallucinations (HP:0002367) | 3.23057437 |
11 | Genetic anticipation (HP:0003743) | 3.06183967 |
12 | Absence seizures (HP:0002121) | 3.04697978 |
13 | Excessive salivation (HP:0003781) | 3.02280654 |
14 | Drooling (HP:0002307) | 3.02280654 |
15 | Myokymia (HP:0002411) | 2.99776192 |
16 | T lymphocytopenia (HP:0005403) | 2.99436027 |
17 | Action tremor (HP:0002345) | 2.97280840 |
18 | Truncal ataxia (HP:0002078) | 2.95571019 |
19 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.94270159 |
20 | Impaired smooth pursuit (HP:0007772) | 2.93533762 |
21 | Broad-based gait (HP:0002136) | 2.91782205 |
22 | Volvulus (HP:0002580) | 2.89968176 |
23 | Generalized tonic-clonic seizures (HP:0002069) | 2.86425101 |
24 | Hyporeflexia of lower limbs (HP:0002600) | 2.85421039 |
25 | Muscle fiber inclusion bodies (HP:0100299) | 2.84492914 |
26 | Exercise-induced myalgia (HP:0003738) | 2.82418119 |
27 | Hyperkalemia (HP:0002153) | 2.79429246 |
28 | Abnormality of the fingertips (HP:0001211) | 2.77365863 |
29 | Protruding tongue (HP:0010808) | 2.75252746 |
30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75167070 |
31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.73198378 |
32 | Subaortic stenosis (HP:0001682) | 2.73198378 |
33 | Spontaneous hematomas (HP:0007420) | 2.72355738 |
34 | Hemiparesis (HP:0001269) | 2.71921985 |
35 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.71718062 |
36 | Dialeptic seizures (HP:0011146) | 2.71595978 |
37 | Dysmetric saccades (HP:0000641) | 2.66830266 |
38 | Nemaline bodies (HP:0003798) | 2.66512148 |
39 | Heterotopia (HP:0002282) | 2.62522984 |
40 | Abnormality of T cell number (HP:0011839) | 2.62076093 |
41 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.58654836 |
42 | Abnormality of the lower motor neuron (HP:0002366) | 2.53908373 |
43 | Dysdiadochokinesis (HP:0002075) | 2.49521376 |
44 | Absent speech (HP:0001344) | 2.48760016 |
45 | Poor eye contact (HP:0000817) | 2.48660906 |
46 | Hyperventilation (HP:0002883) | 2.45244080 |
47 | Subacute progressive viral hepatitis (HP:0006572) | 2.44453155 |
48 | Depression (HP:0000716) | 2.43520486 |
49 | Impaired social interactions (HP:0000735) | 2.42905016 |
50 | Abnormal social behavior (HP:0012433) | 2.42905016 |
51 | Postural instability (HP:0002172) | 2.40781524 |
52 | Eczematoid dermatitis (HP:0000976) | 2.40084469 |
53 | Colitis (HP:0002583) | 2.37177153 |
54 | Aqueductal stenosis (HP:0002410) | 2.35021007 |
55 | Lower limb amyotrophy (HP:0007210) | 2.33403025 |
56 | Urinary urgency (HP:0000012) | 2.31928499 |
57 | Frequent falls (HP:0002359) | 2.31377474 |
58 | Obsessive-compulsive behavior (HP:0000722) | 2.30856231 |
59 | Truncal obesity (HP:0001956) | 2.25184650 |
60 | Abnormal hair whorl (HP:0010721) | 2.23068315 |
61 | Hemiplegia (HP:0002301) | 2.21190747 |
62 | Absent frontal sinuses (HP:0002688) | 2.20082075 |
63 | Scanning speech (HP:0002168) | 2.18941188 |
64 | Inappropriate behavior (HP:0000719) | 2.18305867 |
65 | Calf muscle hypertrophy (HP:0008981) | 2.17850257 |
66 | Blue irides (HP:0000635) | 2.17118268 |
67 | Supranuclear gaze palsy (HP:0000605) | 2.16374314 |
68 | Epileptiform EEG discharges (HP:0011182) | 2.16108548 |
69 | EMG: neuropathic changes (HP:0003445) | 2.15956459 |
70 | Recurrent bacterial skin infections (HP:0005406) | 2.14997504 |
71 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.13861091 |
72 | Neonatal hypoglycemia (HP:0001998) | 2.12268845 |
73 | Slow saccadic eye movements (HP:0000514) | 2.12077465 |
74 | Termporal pattern (HP:0011008) | 2.11845135 |
75 | Insidious onset (HP:0003587) | 2.11845135 |
76 | Narrow palate (HP:0000189) | 2.10330853 |
77 | Open mouth (HP:0000194) | 2.09764093 |
78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09339277 |
79 | Insomnia (HP:0100785) | 2.07921425 |
80 | Papillary thyroid carcinoma (HP:0002895) | 2.05012591 |
81 | Muscle fiber splitting (HP:0003555) | 2.03015283 |
82 | Diplopia (HP:0000651) | 2.02691979 |
83 | Abnormality of binocular vision (HP:0011514) | 2.02691979 |
84 | Thyroid carcinoma (HP:0002890) | 2.01946552 |
85 | Type 1 muscle fiber predominance (HP:0003803) | 2.00815561 |
86 | Abnormality of salivation (HP:0100755) | 2.00078516 |
87 | Overgrowth (HP:0001548) | 1.98558131 |
88 | Short chin (HP:0000331) | 1.98080390 |
89 | Ankle clonus (HP:0011448) | 1.97768971 |
90 | Pointed chin (HP:0000307) | 1.97740011 |
91 | Impaired vibratory sensation (HP:0002495) | 1.97094569 |
92 | Dysmetria (HP:0001310) | 1.96940584 |
93 | Gingivitis (HP:0000230) | 1.96107682 |
94 | Widely spaced teeth (HP:0000687) | 1.95279616 |
95 | Hypsarrhythmia (HP:0002521) | 1.93670163 |
96 | Papilledema (HP:0001085) | 1.92892871 |
97 | Bradykinesia (HP:0002067) | 1.91186325 |
98 | Sandal gap (HP:0001852) | 1.90987990 |
99 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.89974406 |
100 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.89974406 |
101 | Exotropia (HP:0000577) | 1.89842643 |
102 | Stereotypic behavior (HP:0000733) | 1.88545585 |
103 | Acute myeloid leukemia (HP:0004808) | 1.88515382 |
104 | Viral hepatitis (HP:0006562) | 1.87892932 |
105 | Generalized hypopigmentation of hair (HP:0011358) | 1.87674526 |
106 | Abnormality of the corticospinal tract (HP:0002492) | 1.87035462 |
107 | Prominent nose (HP:0000448) | 1.86667951 |
108 | Germ cell neoplasia (HP:0100728) | 1.86240613 |
109 | Recurrent fungal infections (HP:0002841) | 1.84515448 |
110 | Distal arthrogryposis (HP:0005684) | 1.84512674 |
111 | Central scotoma (HP:0000603) | 1.84444717 |
112 | Elfin facies (HP:0004428) | 1.84134743 |
113 | Hematochezia (HP:0002573) | 1.83267579 |
114 | Amblyopia (HP:0000646) | 1.83239793 |
115 | Sudden death (HP:0001699) | 1.82332835 |
116 | Spastic gait (HP:0002064) | 1.79722948 |
117 | Chest pain (HP:0100749) | 1.78021925 |
118 | Gastrointestinal infarctions (HP:0005244) | 1.77505349 |
119 | Lower limb muscle weakness (HP:0007340) | 1.76755757 |
120 | Congenital stationary night blindness (HP:0007642) | 1.75507414 |
121 | EMG: myopathic abnormalities (HP:0003458) | 1.75454480 |
122 | Conjunctival telangiectasia (HP:0000524) | 1.75254553 |
123 | Deeply set eye (HP:0000490) | 1.72818856 |
124 | Thyroiditis (HP:0100646) | 1.72118369 |
125 | Long clavicles (HP:0000890) | 1.70893472 |
126 | Agitation (HP:0000713) | 1.69986287 |
127 | Anxiety (HP:0000739) | 1.69937201 |
128 | Status epilepticus (HP:0002133) | 1.69060476 |
129 | Submucous cleft hard palate (HP:0000176) | 1.68862047 |
130 | Recurrent abscess formation (HP:0002722) | 1.67867851 |
131 | Autism (HP:0000717) | 1.67582013 |
132 | Hyperacusis (HP:0010780) | 1.67419383 |
133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.67300035 |
134 | Resting tremor (HP:0002322) | 1.67016403 |
135 | Dislocated radial head (HP:0003083) | 1.64616485 |
136 | Inflammation of the large intestine (HP:0002037) | 1.64026940 |
137 | Gingival bleeding (HP:0000225) | 1.63624634 |
138 | Abnormality of the nasal septum (HP:0000419) | 1.63507982 |
139 | Abnormality of the ischium (HP:0003174) | 1.63286557 |
140 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.63000527 |
141 | Prolonged bleeding time (HP:0003010) | 1.61734600 |
142 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61709804 |
143 | Neoplasm of the heart (HP:0100544) | 1.61040201 |
144 | Poikilocytosis (HP:0004447) | 1.60446452 |
145 | Progressive inability to walk (HP:0002505) | 1.60162392 |
146 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.59994482 |
147 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.59795312 |
148 | Tented upper lip vermilion (HP:0010804) | 1.59348475 |
149 | Abnormality of the astrocytes (HP:0100707) | 1.56294773 |
150 | Astrocytoma (HP:0009592) | 1.56294773 |
151 | Fair hair (HP:0002286) | 1.56187889 |
152 | Intention tremor (HP:0002080) | 1.53654441 |
153 | Mask-like facies (HP:0000298) | 1.53275958 |
154 | Hypochromic microcytic anemia (HP:0004840) | 1.52972333 |
155 | Tapered finger (HP:0001182) | 1.52219104 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.97310976 |
2 | MAP3K4 | 3.32482871 |
3 | EPHA4 | 2.84796645 |
4 | OBSCN | 2.77074477 |
5 | MARK1 | 2.63349105 |
6 | MAP3K9 | 2.61337625 |
7 | CAMK1G | 2.50080624 |
8 | MAP2K7 | 2.34703325 |
9 | SIK2 | 2.29203716 |
10 | SGK2 | 2.24154179 |
11 | DAPK2 | 2.02170691 |
12 | RIPK4 | 1.99546109 |
13 | SGK3 | 1.88930566 |
14 | BRD4 | 1.88619627 |
15 | CAMK1D | 1.86370110 |
16 | MINK1 | 1.82894749 |
17 | NTRK2 | 1.82513422 |
18 | BLK | 1.76345809 |
19 | CASK | 1.68165892 |
20 | PIK3CG | 1.67331276 |
21 | PNCK | 1.63076507 |
22 | CDK12 | 1.60628758 |
23 | SGK223 | 1.57350858 |
24 | SGK494 | 1.57350858 |
25 | MAPK13 | 1.53389847 |
26 | MAP2K4 | 1.52585184 |
27 | NLK | 1.47238025 |
28 | TRPM7 | 1.42735589 |
29 | TTN | 1.41402971 |
30 | PAK6 | 1.40599982 |
31 | INSRR | 1.37904030 |
32 | EPHA3 | 1.36361453 |
33 | TNIK | 1.35855563 |
34 | CAMKK1 | 1.31111065 |
35 | MAP3K13 | 1.28155214 |
36 | KSR1 | 1.27894660 |
37 | CDK5 | 1.26347814 |
38 | MAP3K10 | 1.26325295 |
39 | SGK1 | 1.25165182 |
40 | PRKD3 | 1.24704276 |
41 | PRPF4B | 1.23050394 |
42 | MAPK12 | 1.21190651 |
43 | SYK | 1.21040824 |
44 | EEF2K | 1.15041460 |
45 | STK38 | 1.14042348 |
46 | MAP4K1 | 1.13200774 |
47 | BTK | 1.12263139 |
48 | MAP2K3 | 1.10785301 |
49 | WNK1 | 1.08236433 |
50 | FES | 1.06261346 |
51 | TEC | 1.05958738 |
52 | RET | 1.03577295 |
53 | PRKCH | 1.01550101 |
54 | NTRK1 | 1.00996742 |
55 | PLK2 | 1.00770712 |
56 | RIPK1 | 1.00439137 |
57 | CDC42BPA | 0.98179185 |
58 | HCK | 0.95213223 |
59 | ITK | 0.95139749 |
60 | IKBKE | 0.94820697 |
61 | JAK2 | 0.93778974 |
62 | CAMKK2 | 0.93184181 |
63 | DAPK1 | 0.91828710 |
64 | FGFR3 | 0.91287764 |
65 | MAP3K2 | 0.88191942 |
66 | DYRK1A | 0.88077872 |
67 | STK11 | 0.88073435 |
68 | FRK | 0.86504014 |
69 | MAP3K7 | 0.85894815 |
70 | PINK1 | 0.84035518 |
71 | YES1 | 0.83293823 |
72 | MARK3 | 0.82516798 |
73 | KSR2 | 0.81946869 |
74 | AKT3 | 0.80324571 |
75 | CDK9 | 0.79883266 |
76 | MARK2 | 0.79324204 |
77 | JAK3 | 0.78962466 |
78 | CSK | 0.78958385 |
79 | PRKAA2 | 0.78853638 |
80 | CAMK4 | 0.77833735 |
81 | NEK6 | 0.77016517 |
82 | FGFR2 | 0.76528486 |
83 | CAMK1 | 0.75928741 |
84 | FGR | 0.73264980 |
85 | GRK6 | 0.72030103 |
86 | ZAP70 | 0.71464327 |
87 | PTK2B | 0.70490991 |
88 | PHKG1 | 0.70354152 |
89 | PHKG2 | 0.70354152 |
90 | MAPK7 | 0.69226737 |
91 | RPS6KA2 | 0.69208900 |
92 | MAPK10 | 0.68818433 |
93 | RPS6KA3 | 0.68686164 |
94 | ERBB3 | 0.68588238 |
95 | DMPK | 0.67492343 |
96 | SCYL2 | 0.66856713 |
97 | LMTK2 | 0.65492006 |
98 | PRKCG | 0.64193563 |
99 | PDK1 | 0.63788252 |
100 | FGFR4 | 0.63674243 |
101 | LCK | 0.62871991 |
102 | RAF1 | 0.62253287 |
103 | TYK2 | 0.62076903 |
104 | TXK | 0.61847888 |
105 | TNK2 | 0.61128786 |
106 | JAK1 | 0.60395941 |
107 | PIK3CA | 0.59853340 |
108 | GRK5 | 0.59551348 |
109 | PIM1 | 0.59266870 |
110 | CCNB1 | 0.58981988 |
111 | MAP3K1 | 0.58838189 |
112 | CAMK2A | 0.57879702 |
113 | MAP3K14 | 0.57823286 |
114 | TAOK3 | 0.57173003 |
115 | PRKAA1 | 0.56862657 |
116 | TYRO3 | 0.55019688 |
117 | UHMK1 | 0.54171930 |
118 | MAPK8 | 0.53842665 |
119 | RPS6KB1 | 0.52973215 |
120 | PDGFRB | 0.52711700 |
121 | STK4 | 0.52288743 |
122 | ALK | 0.52124797 |
123 | MTOR | 0.52108944 |
124 | GSK3B | 0.51861837 |
125 | HIPK2 | 0.51179551 |
126 | CDK3 | 0.50938290 |
127 | MAPK11 | 0.50136684 |
128 | PKN2 | 0.49434938 |
129 | PRKDC | 0.48428910 |
130 | PRKCB | 0.48018653 |
131 | MAP3K6 | 0.46842436 |
132 | MAPK14 | 0.42332958 |
133 | CSNK1G2 | 0.42235182 |
134 | FYN | 0.41573094 |
135 | PDGFRA | 0.39033246 |
136 | ATM | 0.38446115 |
137 | BMPR2 | 0.38102401 |
138 | PRKG1 | 0.36871531 |
139 | TAOK1 | 0.36757525 |
140 | NUAK1 | 0.36538334 |
141 | PKN1 | 0.36521020 |
142 | CSNK1D | 0.36043137 |
143 | PDPK1 | 0.35826481 |
144 | PAK3 | 0.35795890 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.97706675 |
2 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31776014 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.29965464 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.29722924 |
5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.26623145 |
6 | Morphine addiction_Homo sapiens_hsa05032 | 2.19760937 |
7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.19375104 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.09090519 |
9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.07364465 |
10 | Salivary secretion_Homo sapiens_hsa04970 | 1.93800190 |
11 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90756219 |
12 | Insulin secretion_Homo sapiens_hsa04911 | 1.88170912 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81616130 |
14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.76850508 |
15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69418696 |
16 | Renin secretion_Homo sapiens_hsa04924 | 1.69262349 |
17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67844669 |
18 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.67001182 |
19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65100672 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.61685467 |
21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54878693 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.53853974 |
23 | Long-term depression_Homo sapiens_hsa04730 | 1.50771551 |
24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49727169 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43547195 |
26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43437314 |
27 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.39417399 |
28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35828114 |
29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34449241 |
30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33277698 |
31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28478241 |
32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26875490 |
33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26358027 |
34 | Glioma_Homo sapiens_hsa05214 | 1.24509843 |
35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23313057 |
36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21728433 |
37 | Gap junction_Homo sapiens_hsa04540 | 1.20040796 |
38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17137087 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16733496 |
40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13385536 |
41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09307212 |
42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04769709 |
43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.03116503 |
44 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.02178179 |
45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.00539401 |
46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.99402720 |
47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98804942 |
48 | Phototransduction_Homo sapiens_hsa04744 | 0.98623266 |
49 | Axon guidance_Homo sapiens_hsa04360 | 0.97811870 |
50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96308746 |
51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93858296 |
52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93089226 |
53 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92500983 |
54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92398071 |
55 | Alcoholism_Homo sapiens_hsa05034 | 0.91907643 |
56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90695928 |
57 | Melanogenesis_Homo sapiens_hsa04916 | 0.90185456 |
58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87535742 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87324453 |
60 | Prostate cancer_Homo sapiens_hsa05215 | 0.86579587 |
61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86440145 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86384844 |
63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84966313 |
64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84712949 |
65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83760872 |
66 | Measles_Homo sapiens_hsa05162 | 0.81922903 |
67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79785592 |
68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78960158 |
69 | Hepatitis B_Homo sapiens_hsa05161 | 0.78401540 |
70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78290517 |
71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78084706 |
72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77215449 |
73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76255843 |
74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76110678 |
75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75355350 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.75134842 |
77 | Tuberculosis_Homo sapiens_hsa05152 | 0.75118732 |
78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74315068 |
79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74157621 |
80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73665903 |
81 | ABC transporters_Homo sapiens_hsa02010 | 0.73131363 |
82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70433680 |
83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.70319632 |
84 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69962888 |
85 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69247837 |
86 | Adherens junction_Homo sapiens_hsa04520 | 0.68888541 |
87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67513232 |
88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66725595 |
89 | Focal adhesion_Homo sapiens_hsa04510 | 0.64054162 |
90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63325511 |
91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62905049 |
92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61597967 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60933444 |
94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60673474 |
95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60556138 |
96 | Influenza A_Homo sapiens_hsa05164 | 0.60285294 |
97 | Hepatitis C_Homo sapiens_hsa05160 | 0.60107000 |
98 | Lysine degradation_Homo sapiens_hsa00310 | 0.59389385 |
99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59303699 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59230401 |
101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59134855 |
102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58993543 |
103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58257070 |
104 | Platelet activation_Homo sapiens_hsa04611 | 0.58241961 |
105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57854827 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57142415 |
107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56922097 |
108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56344087 |
109 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54702555 |
110 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53731273 |
111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51271878 |
112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50734175 |
113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50685779 |
114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49471439 |
115 | Insulin resistance_Homo sapiens_hsa04931 | 0.47765936 |
116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47705902 |
117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47165902 |
118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47056321 |
119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46526342 |
120 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45628047 |
121 | Endocytosis_Homo sapiens_hsa04144 | 0.45052232 |
122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43393615 |
123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42467286 |
124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.41420536 |
125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39396740 |